The Blue Box Biomedical Solutions
Seed Round in 2024
Women aged 20-45 cannot get screened for breast cancer because existing solutions are unreliable. However, 81% want to. At The Blue Box, we have built a pain-free, low-cost, sensitive, radiation-free device to detect breast cancer in urine with a sensitivity of 83%. In 2024, we’ll launch into the market, bringing The Blue Box to private gynecology clinics with a Diagnostics-as-a-Service subscription model, and a pay-per-test revenue stream that we’ll share with doctors.
Meela AB is a mental health service provider that specializes in connecting women with psychologists and psychotherapists through a user-friendly platform. By utilizing a matching algorithm, Meela effectively pairs individuals with therapists based on their specific profiles and needs, ensuring a personalized therapy experience. The service offers both online and in-person therapy sessions and is designed to assist individuals dealing with mild to moderate mental health issues. Meela prioritizes enhancing the therapeutic alliance and aims to reduce the likelihood of premature termination of therapy, making it a valuable resource for women seeking mental health support in Sweden.
Climate X
Series A in 2024
Climate X is a global climate physical risk data analytics company that specializes in climate risk management services. The firm provides tools to project and predict the impacts of climate change and extreme weather events by integrating climate models with current real-world data. Through its physical modeling capabilities, Climate X enables businesses and governments to anticipate regulatory requirements and adapt to evolving climate-related challenges. Its clientele includes prominent financial institutions in sectors such as banking, real estate, and insurance, highlighting its relevance in a rapidly changing climate landscape.
Cellugy
Seed Round in 2024
Cellugy is a biotechnology company developing cellulose-based materials to replace single-use plastics. It uses a fermentation platform that converts renewable resources into natural bio-cellulose, delivering cellulose with quality comparable to natural sources while offering competitive economics and a smaller environmental footprint. By substituting petrochemicals in products with this bio-cellulose, the company aims to maintain production momentum and performance. The technology enables the production of different grades and qualities of cellulose, enabling applications across multiple industries, including personal care, packaging, textiles, and food. The company focuses on providing sustainable alternatives and reducing reliance on fossil-based plastics, positioning itself at the intersection of materials science and circular economy.
Saveggy
Seed Round in 2024
Producer of edible, bio-based, and food-safe packaging intended to reduce food loss and waste along the supply chain through sustainable alternatives. The company's platform technology is fully scalable and is the only available edible alternative that complies with EU regulations for fruits and vegetables with edible peels, enabling clients to ensure more food reaches consumers around the world.
Moonhub
Venture Round in 2024
Moonhub is a London-based company that specializes in virtual reality training solutions for organizations. Established in 2016, it offers an immersive platform that allows employees to engage in interactive role-play scenarios, enhancing their learning and retention of knowledge. The use of advanced, remotely deployable technology coupled with a patented data capture system distinguishes Moonhub's approach, enabling businesses to optimize their training processes and unlock the full potential of their workforce.
Octarine Bio
Series A in 2023
Octarine Bio is a biotechnology company based in Copenhagen, Denmark, founded in 2018. The company specializes in the research and development of cannabinoid and psilocybin derivatives, utilizing synthetic biology to create a range of natural and novel compounds. Through its biosynthetic platform, Octarine Bio focuses on producing superior cannabinoids aimed at the pharmaceutical industry, improving pharmacokinetic and therapeutic properties. Its innovative approach enables healthcare professionals to better address neurological and psychological disorders, ultimately enhancing health and well-being.
LEIA Health
Pre Seed Round in 2023
Developer of a post-pregnancy and parental health application intended to digitize the parental journey. The company's platform offers AI-powered support at a time when parents need it the most, decreasing health inequities by personalizing the postpartum recovery journey as well as the parental leave process to drive positive health outcomes and support parents in the workforce, it personalized insights about their mental and physical health, medically validated information, and tools to optimize health, screening models for postpartum depression and pelvic floor complications, enabling women to identify risk at a much earlier stage and guide them to the correct healthcaremore
Alba Health is a company focused on enhancing children's gut health through digital solutions and advanced microbiome testing. It offers an innovative stool test kit designed for easy use, allowing parents to analyze their child's gut microbiome in a certified laboratory. Upon completion of the analysis, detailed results are provided, which enable parents to collaborate with dieticians in formulating personalized action plans for their children's dietary and health needs. Additionally, Alba Health places significant emphasis on data privacy by anonymizing test results, which can contribute to broader discoveries that positively influence children's health outcomes. The company's overarching mission is to improve the health of future generations by leveraging artificial intelligence and microbiome science.